Discover how specific mutations in ARS genes cause inherited peripheral neuropathies and potential avenues for targeted ...
The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results